➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Medtronic
Express Scripts
Baxter

Last Updated: September 25, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091496


Email this page to a colleague

« Back to Dashboard

NDA 091496 describes NITROGLYCERIN, which is a drug marketed by Hercon Pharm, Lannett Co Inc, Mylan Technologies, Abraxis Pharm, Am Regent, Hospira, Intl Medication, Luitpold, Smith And Nephew, Fougera Pharms Inc, Perrigo Israel, Actavis Labs Fl Inc, Alvogen, Dr Reddys, Glenmark Pharms Sa, Rubicon, Sigmapharm Labs Llc, and Baxter Hlthcare, and is included in twenty-seven NDAs. It is available from sixteen suppliers. Additional details are available on the NITROGLYCERIN profile page.

The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 091496
Tradename:NITROGLYCERIN
Applicant:Perrigo Israel
Ingredient:nitroglycerin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 091496
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 091496
Suppliers and Packaging for NDA: 091496
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NITROGLYCERIN nitroglycerin SPRAY, METERED;SUBLINGUAL 091496 ANDA Perrigo New York Inc 45802-210 45802-210-01 1 BOTTLE in 1 CARTON (45802-210-01) > 60 SPRAY in 1 BOTTLE
NITROGLYCERIN nitroglycerin SPRAY, METERED;SUBLINGUAL 091496 ANDA Perrigo New York Inc 45802-210 45802-210-02 1 BOTTLE in 1 CARTON (45802-210-02) > 200 SPRAY in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;SUBLINGUALStrength0.4MG/SPRAY
Approval Date:Sep 20, 2013TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Harvard Business School
Moodys
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.